PROPHYLAXIS OF BLEEDING
Clinical trials for PROPHYLAXIS OF BLEEDING explained in plain language.
Never miss a new study
Get alerted when new PROPHYLAXIS OF BLEEDING trials appear
Sign up with your email to follow new studies for PROPHYLAXIS OF BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with severe bleeding disorder: Extended-Release treatment tested
Disease control CompletedThis study tested the safety of an extended-release clotting factor injection called BAY94-9027 (Jivi) in children aged 7-12 with severe hemophilia A. The treatment is designed to last longer in the body, potentially requiring fewer injections to prevent and control bleeding epis…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Apr 04, 2026 07:50 UTC
-
New score aims to tailor bleeding disorder treatment, reduce injections
Disease control CompletedThis study tested a new scoring system to help doctors personalize treatment plans for people with hemophilia A when switching to a longer-lasting medication called Jivi. The score used factors like a person's bleeding history and activity level to assign one of three dosing sche…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC